Day: September 15, 2020

PHILADELPHIA, Sept. 15, 2020 (GLOBE NEWSWIRE) — Brandywine Realty Trust (NYSE:BDN) announced today that its Board of Trustees has declared a quarterly cash dividend of $0.19 per common share and OP Unit payable on October 21, 2020 to holders of record on October 7, 2020.  The quarterly dividend is equivalent to an annual rate of $.76 per share.Conference Call and Audio WebcastWe will release our third quarter earnings after the market close on Wednesday, October 21, 2020, and will hold our third quarter conference call on Thursday, October 22, 2020 at 9:00 a.m. Eastern.  The conference call can be accessed by dialing 1-833-818-6810 and providing conference ID: 5622568.  Beginning two hours after the conference call, a taped replay of the call can be accessed through Friday, November 6, 2020, by calling 1-855-859-2056 and entering...

Net asset value (NAV) of Baltic Horizon Fund (the Fund) unit as at end of August 2020 amounted to EUR 1.2181 per unit. Total net asset value of the Fund rose to EUR 138.1 million over the month. Compared to the previous month, NAV increased by +0.69%. The NAV was affected positively by the operating performance of properties and cash flow hedge movement during the month. EPRA NAV, EPRA NRV and EPRA NTA as at the end of August 2020 increased to EUR 1.3060 per unit, corresponding to an increase of +0.63% over the last month.Consolidated net rental income for the first 8 months of the year amounted to EUR 13.6 million, exceeding the previous year’s net rental income for the same period by EUR 1.8 million or +15.3% (EUR 11.8 million during the eight months ended 31 August 2019). The strong growth was driven by the acquisitions of Galerija...

Net asset value (NAV) of Baltic Horizon Fund (the Fund) unit as at end of August 2020 amounted to EUR 1.2181 per unit. Total net asset value of the Fund rose to EUR 138.1 million over the month. Compared to the previous month, NAV increased by +0.69%. The NAV was affected positively by the operating performance of properties and cash flow hedge movement during the month. EPRA NAV, EPRA NRV and EPRA NTA as at the end of August 2020 increased to EUR 1.3060 per unit, corresponding to an increase of +0.63% over the last month.Consolidated net rental income for the first 8 months of the year amounted to EUR 13.6 million, exceeding the previous year’s net rental income for the same period by EUR 1.8 million or +15.3% (EUR 11.8 million during the eight months ended 31 August 2019). The strong growth was driven by the acquisitions of Galerija...

Baltic Horizon Fondi (Fond) osaku puhasväärtus (NAV) 2020. aasta augusti lõpu seisuga on 1,2181 eurot osaku kohta. Fondi kogu puhasväärtus tõusis kuuga 138,1 miljoni euroni. Fondi osaku puhasväärtuse muutus võrreldes eelneva kuu lõpu seisuga on +0.69%. Fondi puhasväärtust mõjutas positiivselt renditegevusest teenitud rahavoog ning muutus rahavoogude riskimaandamisinstrumendi reservis. EPRA NAV, EPRA NRV ja EPRA NTA kasvas 2020. aasta augusti lõpu seisuga 1,3060 euroni osaku kohta, mis tähendab +0.63% kasvu võrreldes eelmise kuuga.Aasta esimese 8 kuu konsolideeritud puhas renditulu ulatus 13,6 miljoni euroni, ületades eelmise aasta sama perioodi renditulu 1,8 miljoni euro ehk + 15,3% võrra (11,8 miljonit eurot 31. augustil 2019. aastal lõppenud kaheksa kuu jooksul). Tugeva kasvu taga olid Galerija Centrs`i ja North Star`i omandamised,...

Press ReleaseSeptember 15, 2020 – N° 20SCOR welcomes Fitch’s decision to confirm itsInsurer Financial Strength Rating of ‘AA-’and its outlook as stableSCOR has been informed of Fitch’s decision to affirm the Group’s Financial Strength Rating of ‘AA-‘ (Very Strong) and Long-Term Issuer Default Rating (IDR) of ‘A+’. Fitch has also affirmed the ratings of SCOR’s core operating subsidiaries. The outlooks are stable.According to Fitch, this decision reflects “SCOR’s “Favourable” business profile within the global reinsurance sector, “Very Strong” risk-adjusted capitalization and “Strong” financial performance.”Fitch Ratings ranks SCOR’s business profile as “Favourable” compared to that of all other reinsurance companies, as it belongs to a small group of global reinsurers with the scale and financial strength to attract...

Communiqué de presse15 septembre 2020 – N° 20SCOR salue la décision de Fitch de confirmerla note de solidité financière du Groupe à « AA- »et sa perspective à « stable »SCOR a été informé de la décision de l’agence de notation Fitch de confirmer sa note de solidité financière à « AA- » (très forte), ainsi que sa note de crédit émetteur à « A+ ». Fitch a également affirmé les notes des filiales opérationnelles de SCOR. Ces notations ont une perspective stable.Selon Fitch, cette décision reflète « le profil commercial “favorable” de SCOR au sein du secteur mondial de la réassurance, sa capitalisation ajustée aux risques “très robuste” et sa performance financière “robuste” ».Fitch juge le profil commercial de SCOR « favorable » par rapport à celui des autres réassureurs, car SCOR appartient au petit cercle des réassureurs mondiaux...

TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) — VITALHUB CORP. (TSXV: VHI) (the “Company” or “VitalHub”), is pleased to announce that it has closed a non-brokered private placement (the “Offering”) of 1,000,000 common shares (“Shares”) at a price per Share of $2.20 for total gross proceeds to the Company of $2,200,000.Use of proceeds from the Offering will be for future acquisition purposes, to advance the Company’s M&A strategy. On completion of the Offering, VitalHub has 29,238,539 common shares issued and outstanding. The Shares are subject to a four month and one day restriction from trading as of the date of issuance.Connection 25 Inc., a corporation wholly-owned and controlled by Francis Shen, a director of the Company, has subscribed for the full Offering of 1,000,000 Shares. Pursuant to Multilateral Instrument 61-101 Protection...

RENO, Nev., Sept. 15, 2020 (GLOBE NEWSWIRE) — Ormat Technologies, Inc. (NYSE: ORA) today announced that Empresa Nacional de Energia Electrica, (ENEE), its customer for its Platanares geothermal power plant in Honduras, has paid the $20 million overdue payment that was outstanding from prior years.“While expected as we discussed in August, we are pleased to have received all prior years outstanding payment from ENEE,” commented Doron Blachar, Chief Executive Officer. “Ormat provides one of the lowest cost renewable base load electricity to the population of Honduras, and we look forward to continuing our strong relationship with ENEE to develop prospects for additional geothermal power capacity in Honduras.”Ormat is continuing to explore a new 20 MW geothermal prospect in the center of Honduras and currently intends to expedite its...

NEW HAMPTON, N.Y., Sept. 15, 2020 (GLOBE NEWSWIRE) — Balchem Corporation (NASDAQ: BCPC) Chairman of the Board, Chief Executive Officer, and President Ted Harris and Chief Financial Officer Martin Bengtsson will present at the Sidoti Fall 2020 Virtual Investor Conference on Wednesday, September 23, 2020.  Balchem’s presentation will begin at 2:30 p.m. (EDT).A live webcast of the presentation can be accessed through the below link.https://sidoti.zoom.us/webinar/register/WN_5yadp9mvSzyj087eLxiLKAA replay of this presentation will be available approximately 24 hours after the conclusion and will remain available through December 23, 2020.About Balchem CorporationBalchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art...

Mehr als 450 der geplanten ca. 500 Patienten rekrutiertVorläufige Überlegenheitsanalyse wird für Ende 2020 erwartetTelefonkonferenz mit Meinungsführer Dr. Manuel Hidalgo am 29. September 2020 um 10:00 Uhr ETLYON (Frankreich) und CAMBRIDGE, Massachusetts (USA), Sept. 15, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), ein biopharmazeutisches Unternehmen im Bereich der klinischen Forschung, das innovative Therapien entwickelt, bei denen Arzneimittelwirkstoffe in roten Blutkörperchen eingekapselt werden, kündigt die Ausrichtung einer Veranstaltung mit wichtigen Meinungsführern an, um in diesem Rahmen den medizinischen Bedarf bei Pankreaskrebs und die mögliche Rolle von Eryaspase zu erörtern.Für TRYbeCA-1, die klinische Phase-III-Zulassungsstudie zur Beurteilung des Hauptproduktkandidaten von ERYTECH, Eryaspase,...